000710.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:04):

Stats
Today's Volume	10.04M
Average Volume	18.97M
Market Cap	2.85B
EPS	CNY-0.113 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-7.04
ATR14	CNY0 (0.00%)

Volume Correlation

Long: 0.00 (neutral)

Short: 0.00 (neutral)

Signal:(0) Neutral

Berry Genomics Co.,Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Berry Genomics Co.,Ltd Correlation - Currency/Commodity

0.00
( neutral )

Berry Genomics Co.,Ltd Financials

Annual	2022
Revenue:	CNY1.37B
Gross Profit:	CNY584.36M (42.72 %)
EPS:	CNY-0.710

Q3	2023
Revenue:	CNY304.91M
Gross Profit:	CNY148.24M (48.62 %)
EPS:	CNY-0.110

Q2	2023
Revenue:	CNY280.49M
Gross Profit:	CNY110.45M (39.38 %)
EPS:	CNY-0.210

Q1	2023
Revenue:	CNY280.21M
Gross Profit:	CNY132.88M (47.42 %)
EPS:	CNY-0.0569

Financial Reports:

No articles found.

Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics company, develops and commercializes technologies for the life sciences and clinical applications in China. The company offers NGS- based tests for various genetic diseases and cancers from preconception to adulthood; WES test for inherited pathogenic mutations in the GCH1 gene associated with the metabolic disease Dopa-responsive dystonia; CNV-Seq test for indicating translocation at the end of chromosomes 2 and 8; RNA-Seq test to demonstrate the photo-induced protein dimerization of plant cryptochromes; and WGS test for genome wide detection of DNA variants, including SNP, CNV, Indel, and SV. It serves approximately 2,000 hospitals throughout Mainland China, Hong Kong, Macao, and Taiwan. The company serves various organizations and facilities, including hospitals, research institutions, universities, and corporations. Berry Genomics Co.,Ltd has a partnership with Personalis, Inc. The company was founded in 2010 and is headquartered in Beijing, China.